Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Nature Aging
|
April 28, 2023
RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson's disease
David W Craig, Elizabeth Hutchins, Ivo Violich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
Journal of Neurochemistry
|
August 21, 2018
Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study
Brit Mollenhauer, Frederick DuBois Bowman, Daniel Drake, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Science Advances
|
February 9, 2022
Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy
Sheng-Han Kuo, Inmaculada Tasset, Melody M Cheng, et al.
Annals of Clinical and Translational Neurology
|
December 15, 2020
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder
Lana M Chahine, Michael C Brumm, Chelsea Caspell-Garcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 6, 2021
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD<sub>GBA</sub>
Stefanie Lerche, Claudia Schulte, Isabel Wurster, et al.
NPJ Parkinson'S Disease
|
February 11, 2023
A proteogenomic view of Parkinson's disease causality and heterogeneity
Sergio Kaiser, Luqing Zhang, Brit Mollenhauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Cancer Research
|
October 21, 2025
Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State
Youssef El Laithy, Willy Antoni Abreu De Oliveira, Anirudh Pabba, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Nature Aging
|
April 28, 2023
RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson's disease
David W Craig, Elizabeth Hutchins, Ivo Violich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 4, 2021
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Thomas Kremer, Kirsten I Taylor, Juliane Siebourg-Polster, et al.
Journal of Neurochemistry
|
August 21, 2018
Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study
Brit Mollenhauer, Frederick DuBois Bowman, Daniel Drake, et al.
The Lancet. Neurology
|
November 4, 2019
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, et al.
Science Advances
|
February 9, 2022
Mutant glucocerebrosidase impairs α-synuclein degradation by blockade of chaperone-mediated autophagy
Sheng-Han Kuo, Inmaculada Tasset, Melody M Cheng, et al.
Annals of Clinical and Translational Neurology
|
December 15, 2020
Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder
Lana M Chahine, Michael C Brumm, Chelsea Caspell-Garcia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 6, 2021
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PD<sub>GBA</sub>
Stefanie Lerche, Claudia Schulte, Isabel Wurster, et al.
NPJ Parkinson'S Disease
|
February 11, 2023
A proteogenomic view of Parkinson's disease causality and heterogeneity
Sergio Kaiser, Luqing Zhang, Brit Mollenhauer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2020
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, et al.
Cancer Research
|
October 21, 2025
Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State
Youssef El Laithy, Willy Antoni Abreu De Oliveira, Anirudh Pabba, et al.
Page
of 10